Literature DB >> 19553543

Cathepsin S regulates class II MHC processing in human CD4+ HLA-DR+ T cells.

Cristina Maria Costantino1, Hidde L Ploegh, David A Hafler.   

Abstract

Although it has long been known that human CD4(+) T cells can express functional class II MHC molecules, the role of lysosomal proteases in the T cell class II MHC processing and presentation pathway is unknown. Using CD4(+) T cell clones that constitutively express class II MHC, we determined that cathepsin S is necessary for invariant chain proteolysis in T cells. CD4(+)HLA-DR(+) T cells down-regulated cathepsin S expression and activity 18 h after activation, thereby ceasing nascent class II MHC product formation. This blockade resulted in the loss of the invariant chain fragment CLIP from the cell surface, suggesting that-like professional APC-CD4(+) HLA-DR(+) cells modulate self-Ag presentation as a consequence of activation. Furthermore, cathepsin S expression and activity, and concordantly cell surface CLIP expression, was reduced in HLA-DR(+) CD4(+) T cells as compared with B cells both in vitro and ex vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553543      PMCID: PMC2752291          DOI: 10.4049/jimmunol.0900921

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

Review 1.  Proteases involved in MHC class II antigen presentation.

Authors:  J A Villadangos; R A Bryant; J Deussing; C Driessen; A M Lennon-Duménil; R J Riese; W Roth; P Saftig; G P Shi; H A Chapman; C Peters; H L Ploegh
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

Review 2.  Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells.

Authors:  A Lanzavecchia; F Sallusto
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

3.  Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization.

Authors:  Till A Röhn; Marianne Boes; Dirk Wolters; Sebastian Spindeldreher; Bernd Müller; Hanno Langen; Hidde Ploegh; Anne B Vogt; Harald Kropshofer
Journal:  Nat Immunol       Date:  2004-08-22       Impact factor: 25.606

4.  Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro.

Authors:  H Beck; G Schwarz; C J Schröter; M Deeg; D Baier; S Stevanovic; E Weber; C Driessen; H Kalbacher
Journal:  Eur J Immunol       Date:  2001-12       Impact factor: 5.532

5.  Secreted cathepsin L generates endostatin from collagen XVIII.

Authors:  U Felbor; L Dreier; R A Bryant; H L Ploegh; B R Olsen; W Mothes
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

6.  Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III.

Authors:  Tjadine M Holling; Nienke van der Stoep; Edwin Quinten; Peter J van den Elsen
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

7.  Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages.

Authors:  G P Shi; R A Bryant; R Riese; S Verhelst; C Driessen; Z Li; D Bromme; H L Ploegh; H A Chapman
Journal:  J Exp Med       Date:  2000-04-03       Impact factor: 14.307

8.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.

Authors:  R L Evans; T J Faldetta; R E Humphreys; D M Pratt; E J Yunis; S F Schlossman
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

9.  Peripheral blood Ia-positive T cells. Increases in certain diseases and after immunization.

Authors:  D T Yu; R J Winchester; S M Fu; A Gibofsky; H S Ko; H G Kunkel
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

10.  Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen- and antigen-activated T cells.

Authors:  H S Ko; S M Fu; R J Winchester; D T Yu; H G Kunkel
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Engineered nanomaterial-induced lysosomal membrane permeabilization and anti-cathepsin agents.

Authors:  Melisa Bunderson-Schelvan; Andrij Holian; Raymond F Hamilton
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

Review 2.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

3.  3-Cyano-3-aza-β-amino Acid Derivatives as Inhibitors of Human Cysteine Cathepsins.

Authors:  Janina Schmitz; Anna-Madeleine Beckmann; Adela Dudic; Tianwei Li; Robert Sellier; Ulrike Bartz; Michael Gütschow
Journal:  ACS Med Chem Lett       Date:  2014-08-11       Impact factor: 4.345

4.  HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.

Authors:  Gaia Vasiliver-Shamis; Michael L Dustin; Catarina E Hioe
Journal:  Viruses       Date:  2010-05-01       Impact factor: 5.048

5.  Why a second look might be worth it: immuno-modulatory therapies in the critically ill patient.

Authors:  Benedikt H Siegler; Thorsten Brenner; Florian Uhle; Sebastian Weiterer; Markus A Weigand; Stefan Hofer
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

6.  Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse.

Authors:  Corey S Moran; Roby J Jose; Erik Biros; Jonathan Golledge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-09       Impact factor: 8.311

7.  Class II MHC self-antigen presentation in human B and T lymphocytes.

Authors:  Cristina Maria Costantino; Eric Spooner; Hidde L Ploegh; David A Hafler
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

Review 8.  Manipulating autophagic processes in autoimmune diseases: a special focus on modulating chaperone-mediated autophagy, an emerging therapeutic target.

Authors:  Fengjuan Wang; Sylviane Muller
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

9.  Recognition of higher order patterns in proteins: immunologic kernels.

Authors:  Robert D Bremel; E Jane Homan
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

10.  Inhibition of acid ceramidase regulates MHC class II antigen presentation and suppression of autoimmune arthritis.

Authors:  Dan Zhao; Laela M Hajiaghamohseni; Xiang Liu; Zdzislaw M Szulc; Aiping Bai; Alicja Bielawska; James S Norris; Sakamuri V Reddy; Yusuf A Hannun; Azizul Haque
Journal:  Cytokine       Date:  2020-07-29       Impact factor: 3.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.